Circulating exosomal mRNA signatures for the early diagnosis of clear cell renal cell carcinoma

BACKGROUND: There are no proven tumor biomarkers for the early diagnosis of clear cell renal cell carcinoma (ccRCC) thus far. This study aimed to identify novel biomarkers of ccRCC based on exosomal mRNA (emRNA) profiling and develop emRNA-based signatures for the early detection of ccRCC. METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales: He, Xing, Tian, Feng, Guo, Fei, Zhang, Fangxing, Zhang, Huiyong, Ji, Jin, Zhao, Lin, He, Jingyi, Xiao, Yutian, Li, Longman, Wei, Chunmeng, Huang, Caihong, Li, Yexin, Zhang, Feng, Yang, Bo, Ye, Huamao, Wang, Fubo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9404613/
https://www.ncbi.nlm.nih.gov/pubmed/36002886
http://dx.doi.org/10.1186/s12916-022-02467-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9404613/
https://www.ncbi.nlm.nih.gov/pubmed/36002886
http://dx.doi.org/10.1186/s12916-022-02467-1

Ejemplares similares